Attempting to reconstitute an unlicensed injectable compound obtained from an unregulated supplier carries serious risks, including microbial contamination, chemical degradation, and severe dosing errors
These outcomes are not caused by the medication directly attacking teeth
Weight regain upon discontinuation is common with all GLP-1 therapies: Clinical data consistently show that weight regain occurs when GLP-1 receptor agonists are discontinued, typically recovering 50-75% of lost weight within 1-2 years
Along with whole grains, fruits, and vegetables, aim for adequate daily protein to support your training and recovery
It is not yet a verdict, and the appropriate posture is engaged skepticism, not enthusiasm
The same studies can be located independently on PubMed using the CAS number (89030-95-5 (GHK-Cu complex)